242 related articles for article (PubMed ID: 22525969)
1. Multiplicity adjustment for composite binary endpoints.
Rauch G; Kieser M
Methods Inf Med; 2012; 51(4):309-17. PubMed ID: 22525969
[TBL] [Abstract][Full Text] [Related]
2. Planning and evaluating clinical trials with composite time-to-first-event endpoints in a competing risk framework.
Rauch G; Beyersmann J
Stat Med; 2013 Sep; 32(21):3595-608. PubMed ID: 23553898
[TBL] [Abstract][Full Text] [Related]
3. Easily applicable multiple testing procedures to improve the interpretation of clinical trials with composite endpoints.
Schüler S; Mucha A; Doherty P; Kieser M; Rauch G
Int J Cardiol; 2014 Jul; 175(1):126-32. PubMed ID: 24861257
[TBL] [Abstract][Full Text] [Related]
4. Bayesian design and analysis of composite endpoints in clinical trials with multiple dependent binary outcomes.
Zaslavsky BG
Pharm Stat; 2013; 12(4):207-12. PubMed ID: 23625660
[TBL] [Abstract][Full Text] [Related]
5. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
Schmidt R; Burkhardt B; Faldum A
Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
[TBL] [Abstract][Full Text] [Related]
6. Adaptive clinical trial designs with blinded selection of binary composite endpoints and sample size reassessment.
Roig MB; Melis GG; Posch M; Koenig F
Biostatistics; 2023 Dec; 25(1):237-252. PubMed ID: 36150142
[TBL] [Abstract][Full Text] [Related]
7. A new approach for sizing trials with composite binary endpoints using anticipated marginal values and accounting for the correlation between components.
Bofill Roig M; Gómez Melis G
Stat Med; 2019 May; 38(11):1935-1956. PubMed ID: 30637797
[TBL] [Abstract][Full Text] [Related]
8. Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables.
Sozu T; Sugimoto T; Hamasaki T
Biom J; 2012 Sep; 54(5):716-29. PubMed ID: 22829198
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous inference of a binary composite endpoint and its components.
Große Ruse M; Ritz C; Hothorn LA
J Biopharm Stat; 2017; 27(1):56-69. PubMed ID: 26881805
[TBL] [Abstract][Full Text] [Related]
10. Power and sample size when multiple endpoints are considered.
Senn S; Bretz F
Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
[TBL] [Abstract][Full Text] [Related]
11. Addressing multiplicity issues of a composite endpoint and its components in clinical trials.
Huque MF; Alosh M; Bhore R
J Biopharm Stat; 2011 Jul; 21(4):610-34. PubMed ID: 21516560
[TBL] [Abstract][Full Text] [Related]
12. Multiplicity Adjustment and Sample Size Calculation in Clinical Trials with Multiple Endpoints: An Industry Survey of Current Practices in Japan.
Sakamaki K; Morita Y; Iba K; Kamiura T; Yoshida S; Ogawa N; Suganami H; Tsuchiya S; Fukimbara S
Ther Innov Regul Sci; 2020 Sep; 54(5):1097-1105. PubMed ID: 32030692
[TBL] [Abstract][Full Text] [Related]
13. Use of composite endpoints in clinical trials.
Sankoh AJ; Li H; D'Agostino RB
Stat Med; 2014 Nov; 33(27):4709-14. PubMed ID: 24833282
[TBL] [Abstract][Full Text] [Related]
14. Statistical grand rounds: design and analysis of studies with binary- event composite endpoints: guidelines for anesthesia research.
Mascha EJ; Sessler DI
Anesth Analg; 2011 Jun; 112(6):1461-71. PubMed ID: 21543784
[TBL] [Abstract][Full Text] [Related]
15. Impact of weighted composite compared to traditional composite endpoints for the design of randomized controlled trials.
Bakal JA; Westerhout CM; Armstrong PW
Stat Methods Med Res; 2015 Dec; 24(6):980-8. PubMed ID: 22275378
[TBL] [Abstract][Full Text] [Related]
16. How to deal with multiple endpoints in clinical trials.
Neuhäuser M
Fundam Clin Pharmacol; 2006 Dec; 20(6):515-23. PubMed ID: 17109645
[TBL] [Abstract][Full Text] [Related]
17. Assessing additional benefit in noninferiority trials.
Kieser M; Stucke K
Biom J; 2016 Jan; 58(1):154-69. PubMed ID: 24979706
[TBL] [Abstract][Full Text] [Related]
18. Selection of composite binary endpoints in clinical trials.
Bofill Roig M; Gómez Melis G
Biom J; 2018 Mar; 60(2):246-261. PubMed ID: 29023990
[TBL] [Abstract][Full Text] [Related]
19. Blinded sample size recalculation in clinical trials with binary composite endpoints.
Sander A; Rauch G; Kieser M
J Biopharm Stat; 2017; 27(4):705-715. PubMed ID: 27295402
[TBL] [Abstract][Full Text] [Related]
20. Consistency-ensured parametric tests for critical events of composite endpoints.
Huque MF; Alosh M; Guerra M
J Biopharm Stat; 2018; 28(1):82-98. PubMed ID: 29144871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
